当前位置:首页 - 行情中心 - 前沿生物-U(688221) - 财务分析

前沿生物-U

(688221)

  

流通市值:64.84亿  总市值:64.84亿
流通股本:3.75亿   总股本:3.75亿

前沿生物-U(688221)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-1.60亿元,每股收益-0.43元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益98152.04万元,未分配利润-211629.04万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产163739.04万元,负债65587.00万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入103,373,939.2258,639,825.8828,328,182.53129,472,935.98
营业总成本262,354,974.69159,170,063.1174,909,155.77405,686,029.6
其他经营收益
营业利润-159,475,988.33-97,148,403.94-44,136,120.43-201,093,560.92
利润总额-159,808,526.07-97,352,610.68-44,121,517.41-201,382,610.39
净利润-159,808,526.07-97,352,610.68-44,121,517.41-201,382,610.39
每股收益
其他综合收益17,530.7616,756.421,559.4611,919.84
综合收益总额-159,790,995.31-97,335,854.28-44,099,957.95-201,370,690.55
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,055,901,026.231,076,719,889.031,130,068,171.691,222,617,812.37
非流动资产:
非流动资产合计581,489,363.29586,508,009.37593,674,627.65589,520,367.36
资产总计1,637,390,389.521,663,227,898.41,723,742,799.341,812,138,179.73
流动负债:
流动负债合计390,421,353.95373,554,542.67415,284,493.23395,204,569.94
非流动负债:
非流动负债合计265,448,633.98245,697,813.11211,246,867.16275,622,212.89
负债合计655,869,987.93619,252,355.78626,531,360.39670,826,782.83
所有者权益(或股东权益):
归属于母公司股东权益合计981,520,401.591,043,975,542.621,097,211,438.951,141,311,396.9
股东权益合计981,520,401.591,043,975,542.621,097,211,438.951,141,311,396.9
负债和股东权益合计1,637,390,389.521,663,227,898.41,723,742,799.341,812,138,179.73
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计88,991,128.8356,576,387.9627,612,104.41191,548,462.53
经营活动现金流出小计240,780,717.43154,804,229.6576,281,432.49364,064,774.58
经营活动产生的现金流量净额-151,789,588.6-98,227,841.69-48,669,328.08-172,516,312.05
投资活动产生的现金流量:
投资活动现金流入小计2,479,193,958.121,556,639,373.5856,036,498.343,441,147,987.75
投资活动现金流出小计2,423,745,665.311,466,219,991.96793,652,130.913,631,929,445.54
投资活动产生的现金流量净额55,448,292.8190,419,381.5462,384,367.43-190,781,457.79
筹资活动产生的现金流量:
筹资活动现金流入小计289,559,879.25216,774,00039,000,000393,926,406.17
筹资活动现金流出小计344,776,026.5293,954,198.3883,419,439.56308,313,707.75
筹资活动产生的现金流量净额-55,216,147.25-77,180,198.38-44,419,439.5685,612,698.42
汇率变动对现金及现金等价物的影响-26,046.19-15,167.51-4,608.064,532.33
现金及现金等价物净增加额-151,583,489.23-85,003,826.04-30,709,008.27-277,680,539.09
期末现金及现金等价物余额97,136,468.59163,716,131.78218,010,949.55248,719,957.82
补充资料:
现金及现金等价物的净增加额--85,003,826.04--277,680,539.09
最新报告期:2025-11-10
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国盛证券张金洋,胡偌碧,陈欣黎-0.53-0.40-0.552025-11-10
国盛证券张金洋,胡偌碧,陈欣黎-0.53-0.40-0.562025-09-08
TOP↑